Silymarin as a flavonoid-type P-glycoprotein inhibitor with impact on the pharmacokinetics of carbamazepine, oxcarbazepine and phenytoin in rats - Ferreira, A; Rodrigues, M; Meirinho, S; Fortuna, A; Falcão, A; Alves, G (Drug Chem Toxicol, 2019)